Fraunhofer Institute for Cell Therapy and Immunology
Mission and guiding principle
The Fraunhofer Institute for Cell Therapy and Immunology IZI investigates and develops solutions to specific problems at the interfaces of medicine, life sciences and engineering.
One of the institute’s main tasks is to conduct contract research for companies, hospitals, diagnostic laboratories and research institutes operating in the field of biotechnology, pharmaceuticals and medical engineering.
The Fraunhofer IZI develops, optimizes and validates methods, materials and products for the business units Drugs, Cell Therapy, Diagnostics and Biobanks.
Its areas of competence lie in cell biology, immunology, drug biochemistry, bioanalytics and bioproduction as well as process development and automation.
In these areas, research specifically focusses on the indications oncology, ischaemia, autoimmune and inflammatory diseases as well as infectious diseases and regenerative medicine.
The institute works in close cooperation with hospital institutions and performs quality tests besides carrying out the GMP-compliant manufacture of clinical test samples. Furthermore, it helps partners obtain manufacturing licenses and permits.